These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients. Carrasco M; Sureda A; Martínez C; Carmona M; Altés A; Martín-Henao GA; Aventín A; Sierra J Ann Hematol; 2002 Dec; 81(12):710-6. PubMed ID: 12483367 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetics of chronic myeloid leukaemia. Chase A; Huntly BJ; Cross NC Best Pract Res Clin Haematol; 2001 Sep; 14(3):553-71. PubMed ID: 11640869 [TBL] [Abstract][Full Text] [Related]
5. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140 [TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386 [TBL] [Abstract][Full Text] [Related]
7. Leukaemias into the 21st century. Part 2: the chronic leukaemias. Gibson J; Iland HJ; Larsen SR; Brown CM; Joshua DE Intern Med J; 2013 May; 43(5):484-94. PubMed ID: 23668266 [TBL] [Abstract][Full Text] [Related]
8. [Chronic myeloid leukemia. State of the art, May 1993]. Hehlmann R Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189 [TBL] [Abstract][Full Text] [Related]
9. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Matsue K; Tabayashi T; Yamada K; Takeuchi M Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146 [TBL] [Abstract][Full Text] [Related]
10. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse. Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438 [TBL] [Abstract][Full Text] [Related]
11. Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. Gómez M; Urbano-Ispizua A; Cervantes F; Fernández-Avilés F; Rovira M; Carreras E Haematologica; 2002 Sep; 87(9):1003-5. PubMed ID: 12217814 [TBL] [Abstract][Full Text] [Related]
12. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase. Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437 [TBL] [Abstract][Full Text] [Related]